Guven, A. T. Et Al. 2023. Baseline Sodium-Glucose Cotransporter-2 Inhibitor Use Strongly Attenuates the Uric Acid-Elevating Effect of Thiazide Exposure. EUROPEAN JOURNAL OF THERAPEUTICS , vol.29, no.4 , 741-747.

Guven, A. T., ÖZDEDE, M., & ŞENER, Y. Z., (2023). Baseline Sodium-Glucose Cotransporter-2 Inhibitor Use Strongly Attenuates the Uric Acid-Elevating Effect of Thiazide Exposure. EUROPEAN JOURNAL OF THERAPEUTICS , vol.29, no.4, 741-747.

Guven, Alper, MURAT ÖZDEDE, And YUSUF ZİYA ŞENER. "Baseline Sodium-Glucose Cotransporter-2 Inhibitor Use Strongly Attenuates the Uric Acid-Elevating Effect of Thiazide Exposure," EUROPEAN JOURNAL OF THERAPEUTICS , vol.29, no.4, 741-747, 2023

Guven, Alper T. Et Al. "Baseline Sodium-Glucose Cotransporter-2 Inhibitor Use Strongly Attenuates the Uric Acid-Elevating Effect of Thiazide Exposure." EUROPEAN JOURNAL OF THERAPEUTICS , vol.29, no.4, pp.741-747, 2023

Guven, A. T. ÖZDEDE, M. And ŞENER, Y. Z. (2023) . "Baseline Sodium-Glucose Cotransporter-2 Inhibitor Use Strongly Attenuates the Uric Acid-Elevating Effect of Thiazide Exposure." EUROPEAN JOURNAL OF THERAPEUTICS , vol.29, no.4, pp.741-747.

@article{article, author={Alper Tuna Guven Et Al. }, title={Baseline Sodium-Glucose Cotransporter-2 Inhibitor Use Strongly Attenuates the Uric Acid-Elevating Effect of Thiazide Exposure}, journal={EUROPEAN JOURNAL OF THERAPEUTICS}, year=2023, pages={741-747} }